These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 11033502

  • 21. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM, Sherman MP, Barr CC, Schaal S.
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Treatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas].
    Oficjalska-Młyńczak J, Zajac-Pytrus H, Marek J, Nizankowska MH.
    Klin Oczna; 2003 Oct; 105(3-4):140-6. PubMed ID: 14552171
    [Abstract] [Full Text] [Related]

  • 24. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
    Hesse L, Schmidt J, Kroll P.
    Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258
    [Abstract] [Full Text] [Related]

  • 25. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Lincoff H, Kreissig I.
    Retina; 2001 Apr; 21(2):191. PubMed ID: 11321154
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection.
    Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A, N S.
    Retina; 2007 Mar; 27(3):329-34. PubMed ID: 17460588
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator.
    Cakir M, Cekiç O, Yilmaz OF.
    Eur J Ophthalmol; 2010 Mar; 20(3):565-71. PubMed ID: 20037915
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Subretinal hemorrhages secondary to age-related macular degeneration: psychological and vision-related functional perspectives.
    Mozaffarieh M, Sacu S, Benesch T, Wedrich A.
    Ophthalmologica; 2008 Mar; 222(3):199-204. PubMed ID: 18497530
    [Abstract] [Full Text] [Related]

  • 33. Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
    Hesse L, Schroeder B, Heller G, Kroll P.
    Retina; 2000 Mar; 20(5):500-5. PubMed ID: 11039425
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm.
    Wu TT, Sheu SJ.
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):62-7. PubMed ID: 15718829
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.